Humacyte (HUMA) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced virtually with executive management, board members, and legal counsel present.

• Voting procedures and eligibility were outlined, with polls open during the meeting.

• Rules of conduct and question submission process were explained for stockholders.

Board and executive committee updates

• Introduction of director nominees John P. Bamforth, Keith Anthony Jones, and Kathleen Sebelius for election as Class II directors until the 2029 annual meeting.

• Board unanimously recommended voting in favor of all director nominees and proposals.

Shareholder proposals

• Advisory vote on executive compensation and frequency of future Say-on-Pay votes presented.

• Proposal to ratify PricewaterhouseCoopers LLP as independent auditor for 2026.

• Proposal to amend certificate of incorporation to increase authorized common stock from 350 million to 550 million shares.